Variation in lung cancer survival rates between countries: do differences in data reporting contribute?

Respiratory Medicine
Claire A ButlerWendy J A Anderson

Abstract

Mortality rates from lung cancer are known to vary considerably between countries. Differences in patients, disease, investigation and treatment are thought to account for some survival shortfalls but it is not known whether differences in collection or processing of data also contribute. We searched recognised sources where information regarding mortality rates have been published for the United Kingdom, Europe and United States (US). Data regarding patient selection, demographics and mortality rates were extracted. Published international 5-year survival for patients with lung cancer varies from 5% to 16%. The survival figures quoted in the literature are based on data which varies widely in its collection and statistical analysis and this information is not always in the public domain. Data from the US suggests an overall 5-year survival rate of up to 16% although this figure covers only a quarter of the general population and excludes patients without histological confirmation. Many European countries report higher mortality rates although in most, data includes patients without proven histology. European datasets have variable population coverage. Selective data collection and variable population coverage may account for s...Continue Reading

References

Jan 1, 1995·Clinical Oncology : a Journal of the Royal College of Radiologists·A Gregor, F Macbeth
Sep 1, 1996·Thorax·J S Billing, F C Wells
Mar 28, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H BrennerT Hakulinen
Aug 28, 2002·Australasian Radiology·Matthew Seel, Farshad Foroudi
Dec 20, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F Berrino
Dec 20, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M P ColemanUNKNOWN EUROCARE Working Group
Apr 2, 2005·BMJ : British Medical Journal·Rory Watson
Oct 1, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Silvia RossiUNKNOWN EUROCARE-5 Working Group:

❮ Previous
Next ❯

Citations

Jan 25, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Erik JakobsenTorben Palshof
Aug 2, 2008·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Danny R YouldenPeter D Baade
Sep 29, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Stephen J O'Connor
Mar 28, 2009·Archivos de bronconeumología·Julio Sánchez De Cos Escuín
Dec 7, 2007·The Lancet Oncology·Wendy J Anderson, Cormac Murtagh
Sep 25, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Julio Sánchez de CosM Angel Alonso
Jun 13, 2009·International Journal of Cancer. Journal International Du Cancer·Hui-Ying LiangBao-Sen Zhou
Jan 1, 2010·Integrative Cancer Therapies·Diana CamposClaudio Sibata
Jun 17, 2020·Journal of Travel Medicine·Esabelle Lo Yan Yam
Sep 3, 2020·Cell Adhesion & Migration·M A Haoyuan, L I Yanshu
Apr 20, 2021·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin ReckJulie R Brahmer
Feb 8, 2018·Preventive Medicine·Nicolas R Ziebarth

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
J FerlayP Boyle
International Journal of Cancer. Journal International Du Cancer
Kenji ShibuyaAlan D Lopez
© 2021 Meta ULC. All rights reserved